Navigation Links
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
Date:9/11/2009

and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.

Forward Looking Statement - Regeneron Pharmaceuticals, Inc.

This news release discusses historical information and includes forward-looking statements about Regeneron and its products, development programs, finances, and business, all of which involve a number of risks and uncertainties, such as risks associated with preclinical and clinical development of aflibercept, determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize aflibercept, competing drugs that may be sup
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.; sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
2. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
3. MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
4. MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
5. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
6. BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
7. Hoviones TwinCaps(R) Inhaler Delivers Successfully in Phase III Clinical Trials for Influenza
8. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
9. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
10. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
11. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Research and Markets ... "Stability Testing of Pharmaceuticals (London, UK - December ... By attending this comprehensive two day seminar delegates will: ... studies that are suitable for global arketing - ... manage stability samples and facilities - Know how ...
(Date:9/4/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... therapies, today announced its financial results for the fiscal ... of recent Company highlights and expected near-term milestones. ... update conference call and live webcast for investors, analysts ...
(Date:9/3/2015)... Sept. 3, 2015  Cipla, a global pharmaceutical company ... needs of all patients, today announced that its UK ... acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan ... conditions, is valued at $550 million and will be ... transactions is over $200 million for the year ended ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... Sanare, LLC, a leading provider of care ... new consumer brand, BrightSky, have become National Strategic ... (Logo: http://photos.prnewswire.com/prnh/20110414/FL83264LOGO) The sponsorship makes Sanare ... Association,s newly diagnosed patient initiative called "Living With ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association 2
(Date:9/4/2015)... ... ... IVF New England, one of the largest and most successful fertility centers in ... women who wish to learn more about their fertility and egg freezing. , Date ... Street, Manchester, NH from 6PM to 7PM , This hip, casual and informative event ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts (SE) announced ... awards at this year’s Microsoft Worldwide Partner Conference that was held in Orlando, ... Award Winner for Data Platform services, the 2015 HP and Microsoft “Outstanding Frontline ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for a quick ... be their solution. , The patent-pending K Med Cups provide a quick and simple way ... to relieve a cold, flu or cough. As a result, they enhance comfort and health. ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces ... neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The first ... feature 30 cottage or “pocket” homes. In this community, adults will live safely ...
(Date:9/4/2015)... NC (PRWEB) , ... September 04, 2015 , ... ... filtration products, has a Labor Day offer that cannot be passed up. ... stock up on necessary air and water filtration product replacements. Take advantage of ...
Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... (March 12, 2008) The American Society of Nephrology ... and The American Society of Pediatric Nephrology (ASPN), will ... 13. Physicians and patient advocates from across the nation ... staff to raise awareness of chronic kidney disease (CKD) ...
... protein well known for its crucial role in regulating gene ... it a key player in the immune system. But SATB1 ... contributing factor in the most aggressive forms of breast cancer. ... metastasis -- the stage when cells break away from the ...
... Philip LoGrasso, associate professor and senior director for drug ... principal investigator. LoGrasso, who joined Scripps Florida in 2005, ... The new five-year grant will fund research to develop ... goal of the project is to bring the potential ...
... lead to earlier treatments, better patient outcomes , , WEDNESDAY, ... test can identify patients at risk of developing acute ... sooner than the problem would otherwise be detected, a ... earlier treatment and better patient outcomes, the researchers say. ...
... Channel 157 to air awards ceremony synopsis, ... Foundation Excellence in Medicine Awards will be,broadcast for ... providing advanced healthcare information and education for medical,professionals. ... 31st at the,Grand Hyatt in Washington D.C. ReachMD,s ...
... Kevin Richardson has joined,Kaiser Permanente as vice ... made by Thomas A. Curtin, senior vice,president, National ... Richardson is responsible for leadership and management of,new ... Permanente,organization for prospective national and multi-state employer group,business., ...
Cached Medicine News:Health News:ASN members visit Capitol Hill to promote World Kidney Day and CKD awareness 2Health News:A protein that triggers aggressive breast cancer 2Health News:A protein that triggers aggressive breast cancer 3Health News:A protein that triggers aggressive breast cancer 4Health News:A protein that triggers aggressive breast cancer 5Health News:Scripps Florida awarded $7.6 million grant to develop novel treatment for Parkinson's disease 2Health News:New Test Predicts Risk of Post-Surgery Kidney Injury 2Health News:AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards 2Health News:Kevin Richardson Named Vice President, Sales, National & Multi-State Business for Kaiser Permanente 2
200 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Inquire...
... Eliminate aerosol contamination, ... reactions in PCR. Hydrophobic, ... Only air can pass ... tips, in contrast to ...
... eliminate false signals and contamination caused ... Promega Barrier Tips offer performance and ... acids (PCR(a)), radioactive isotopes, tissue culture ... specimens. , ,Promega Barrier Tips are ...
Medicine Products: